This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Eric Blanchard
Eric W. Blanchard
Partner
New York +1 212 841 1111 eblanchard@cov.com Download V-card

Eric Blanchard is a partner resident in the firm’s New York office and is a Vice Chair of the Securities & Capital Markets practice group.  Mr. Blanchard’s practice focuses on domestic and international capital markets transactions, as well as governance, securities law reporting and compliance.  Mr. Blanchard has worked on securities offerings involving issuers from a variety of industries, from life sciences and technology to retail and consumer goods.  In addition, Mr. Blanchard has represented both issuers and shareholders in proxy contests and shareholder activism matters.

Governance Matters

  • Illumina, Inc. in connection with a successful proxy defense relating to a hostile takeover bid by Roche.
  • The Board of Trustees of The Ohio State University in connection with a university-wide assessment of the institution’s compliance program, which led to the establishment of a novel Office of University Compliance and Integrity.
  • A large private equity firm in connection with a review of the governance and compliance programs of several of the firm’s portfolio companies.
  • The independent directors of a large life sciences company in connection with corporate governance and compliance matters.

Capital Markets Matters

Investment Grade Debt

  • Johnson & Johnson in multiple offerings of investment-grade notes.
  • Bristol-Myers Squibb Company in an offering of euro-denominated investment-grade notes.
  • Zoetis Inc. in an offering of investment-grade notes.
  • The underwriters in numerous public offerings of investment-grade notes of Jefferies Group, Inc.
  • The underwriters in several public offerings of investment-grade notes of The Clorox Company.
  • The underwriters in numerous public and private offerings of investment-grade notes of Cardinal Health, Inc.
  • The initial purchasers in a private offering of investment-grade notes of CareFusion Corporation in connection with a leveraged spinoff.

IPOs and Follow-on Equity

  • The underwriters in the US IPO of American Depositary Shares of Nabriva Therapeutics AG, an Austria-based biotechnology company focused on developing a new class of antibiotics. 
  • The underwriters in the initial public offering of common stock of Bellicum Pharmaceuticals, Inc., a biotechnology company focused on cellular immunotherapies therapies.
  • The underwriters in the initial public offering and follow-on equity offering of Affimed N.V., a biotechnology company focused on immuno-oncology.
  • The underwriters in the initial public offering and follow-on equity offering of ordinary shares of uniQure N.V., a Netherlands-based biotechnology company focused on gene therapies.
  • The underwriters in the initial public offering and follow-on offering of NeuroDerm Ltd., an Israel-based biotechnology company focused on developing therapies for CNS disease. 
  • The underwriters in the initial public offering of American Depositary Shares of 3SBio Inc., a China-based biotechnology company, which involved the first listing of a China-based biotechnology company on Nasdaq.

Convertible Debt

  • Illumina, Inc. in multiple private offering of convertible notes pursuant to Rule 144A and Regulation S.
  • Acorda Therapeutics, Inc. in a public offering of convertible notes.
  • Central European Media Enterprises, Ltd., a large international media firm, in an exchange of newly issued convertible notes for outstanding convertible notes conducted pursuant to Section 3(a)(9) of the Securities Act.
  • The underwriters in a contemporaneous public offering of convertible notes and common stock of Gevo, Inc., a renewable chemicals and advanced biofuels company.

High Yield Debt

  • Central European Media Enterprises, Ltd., a large international media firm, in a private offering of senior secured notes pursuant to Rule 144A and Regulation S.
  • Cyfrowy Polsat, a leading Polish media firm, in a private offering of senior secured notes pursuant to Rule 144A and Regulation S.

Memberships and Affiliations

  • Society of Corporate Secretaries and Governance Professionals
  • American Bar Association
  • Association of the Bar of the City of New York, Financial Reporting Committee
  • Legal 500 US, Finance - Capital Markets (2010-2016)
  • New York Super Lawyers “Rising Star” (2011-2015)